Superscrypt, a blockchain and Web3-focused venture capital firm backed by Singapore’s state-owned investment firm Temasek, is reportedly seeking a $100 million capital raise to establish a new ...

Superscrypt, a blockchain venture capital company backed by Temasek Holdings, plans to raise up to US$100 million for its second investment fund, according to people familiar with the matter.

Alto Neuroscience (NYSE:ANRO) shares nosedived 66% Wednesday morning, the first trading session, after the company announced its psychiatric drug ALTO-100 had failed a key clinical study.

SINGAPORE - Singapore investment company Temasek is steering its strategy towards companies with clear decarbonisation plans and sustainable business models, with a goal to secure long-term profits.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Fintel reports that on October 23, 2024, Wedbush downgraded their outlook for Alto Neuroscience (NYSE:ANRO) from Outperform to Neutral. Analyst Price Forecast Suggests 636.93% Upside As of October ...

In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Alto Neuroscience, Inc. (ANRO – Research Report), with a price target of $32.00. The company’s shares ...

Singapore’s Temasek Holdings and Saudi Arabia’s Public Investment Fund (PIF) are expected to maintain their credit strength advantage among rated sovereign wealth funds, Moody’s Investors ...

On Tuesday, Alto Neuroscience, Inc. (NYSE:ANRO) revealed that the Phase 2b study of ALTO-100 for major depressive disorder (MDD) did not meet its primary endpoint compared to placebo. The ...